Events & Presentations

Valo Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

Valo Health To Participate in Piper Sandler's 34th Annual Healthcare Conference

Valo Health to Participate in UBS Biotechnology Virtual Private Company Symposium

Valo Health To Participate in Citi's 17th Annual BioPharma Conference

Valo to participate in Morgan Stanley, Putting the Tech in Biotech: Exploring the World of Tech-Enabled Drug Development

Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement

Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments

Valo Health to Participate in Piper Sandler and Goldman Sachs Investor Conferences

Valo Health Appoints Joe Chan as Head of Engineering

Valo to Participate at the BofA Securities 2021 Virtual Tech Solutions for Drug Discovery Conference

Valo to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit

Valo Health to Present at the UBS Global Healthcare Virtual Conference

Valo Health to Present at the BMO BioPharma Spotlight Series

Valo to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence

Valo Health Receives $110 Million in Funding From Koch Disruptive Technologies to Close Series B

Valo Health to Participate in Barclays and Oppenheimer Healthcare Investor Conferences

Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference